-
Gentamycin Sulfate for Reliable Cell Assays
2026-08-23
Learn how Gentamycin Sulfate (SKU A2514) can reduce bacterial confounding in cell viability, proliferation, and cytotoxicity workflows without obscuring antibiotic-related effects. This scenario-based guide connects product specifications with resistance surveillance and practical assay controls for more interpretable results.
-
5X Protein Loading Buffer (Reducing) Guide
2026-08-22
5X Protein Loading Buffer (Reducing) supports denaturing, reducing protein sample preparation before conventional SDS-PAGE electrophoresis. It is intended for workflows requiring disulfide-bond reduction and protein molecular weight separation, not native, active-protein, or non-reducing analyses.
-
Machine Learning Finds New Senolytics
2026-08-21
The Nature Communications study developed cost-effective machine-learning models trained only on published screening data to identify three senolytic compounds: ginkgetin, periplocin, and oleandrin. Its validation strategy shows how computational prioritization can reduce early drug-screening costs while preserving the need for cell-type selectivity, orthogonal assays, and careful interpretation of senescent-cell killing.
-
Machine Learning Discovery of Senolytics
2026-08-20
The reference study shows that relatively simple machine-learning models trained on published screening data can identify senolytic compounds from chemical libraries. Validation of ginkgetin, periplocin, and oleandrin demonstrates a cost-conscious route to senescence research while highlighting the need for cell-type and senescence-modality-specific testing.
-
Dorsomorphin (Compound C): AMPK-to-Bone Signaling
2026-08-20
Dorsomorphin (Compound C) is more than a conventional AMPK probe: its reversible ATP-competitive activity and parallel BMP pathway effects create an opportunity to connect energy sensing, autophagy regulation, iron metabolism modulation, and osteogenic signaling. This thought-leadership article provides a translational framework for using the compound while separating target engagement from pathway confounding.
-
LG 101506: RXR Modulator Research Guide
2026-08-19
LG 101506 is a synthetic RXR modulator for nuclear receptor signaling and chemical biology of RXR research. The product specification defines its chemical identity, 98.00% purity, solvent solubility limits, and −20 °C storage condition, while current TNBC evidence supports a research rationale rather than a demonstrated LG 101506 treatment effect.
-
LG 101506 (RXR modulator) for Reliable Assays
2026-08-19
This scenario-based guide shows how biomedical researchers can use LG 101506 (RXR modulator), SKU B7414, to design more interpretable viability, proliferation, and cytotoxicity experiments. It combines product specifications with practical controls and literature-aware limits for RXR signaling pathway research.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-08-18
Grafton and colleagues developed a high-content screening strategy that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify cardiotoxic phenotypes. The study shows how a single image-derived score can prioritize compounds and chemical frameworks for earlier cardiac safety assessment, while also highlighting the limits of phenotype-based prediction.
-
NADPH Oxidase ROS and Arterial Contraction in Rat Pups
2026-08-18
The reference study identifies L-type voltage-gated Ca2+ channels as the principal downstream effectors of NADPH oxidase-derived ROS in saphenous arteries from early postnatal rats, while excluding Rho-kinase, PKC, and Src-kinase as required mediators of this ROS-dependent pathway. Its pharmacological dissection provides a useful framework for interpreting Src inhibition in vascular experiments without equating reduced overall contraction with direct mediation of the ROS signal.
-
Recombinant Annexin V Purification for Biophysics
2026-08-17
This 1993 study introduced a rapid purification strategy for recombinant annexin V that combined mild osmotic cell opening, calcium-dependent liposome binding, and final ion-exchange chromatography. The workflow produced protein sufficiently pure for crystallography, electron microscopy, spectroscopy, and single-channel measurements, illustrating how purification design can directly determine the feasibility of downstream biophysical research.
-
AEBSF.HCl for Protease-Controlled Cell Death Assays
2026-08-17
AEBSF.HCl provides irreversible, broad-spectrum serine protease control for cell lysis, amyloid precursor protein processing, and protease-sensitive cell-death workflows. Its greatest value is not as a universal cathepsin inhibitor, but as a mechanistically informative perturbation that helps separate serine-protease effects from lysosomal cathepsin biology.
-
(+)-Bicuculline Workflow and QC Guide
2026-08-16
This practical guide explains how to prepare, store, and quality-check (+)-Bicuculline as a GABAA receptor antagonist for controlled neuroscience experiments. It is intended for in vitro neuronal assays and carefully defined in vivo research, not for diagnostic, clinical, or therapeutic use.
-
Abiraterone Acetate in 3D Prostate Cancer Models
2026-08-15
Use Abiraterone acetate as a mechanistic CYP17 inhibitor in patient-derived prostate spheroids, where three-dimensional architecture can expose drug-response patterns that monolayers miss. This guide combines formulation control, treatment design, comparator selection, and troubleshooting for reproducible prostate cancer research.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-14
The reference study identifies CD44 as a functional dependency of IDH-mutant leukemia rather than merely a surface marker. By linking CD44 to pentose phosphate pathway activation, glycolytic suppression, NADPH availability, and R-2HG production, the work provides a rationale for combining CD44 blockade with mutant-IDH inhibition.
-
Nicotinamide Adenine Dinucleotide (NAD+) Workflows
2026-08-14
Build more informative stress-response experiments by pairing NAD+ redox and enzyme assays with autophagy, PARP1, and DNA-damage readouts. This workflow translates the latest CASP3/CASP7 findings into practical assay design while clearly separating evidence from exploratory NAD+ applications.